Table 4.

Study outcomes for whole study population at 30 days. Data are numbers (%)

Outcome	No bridging (n=650)	Bridging (n=820)	P value	Risk difference (95% CI)
Major thromboembolism	8 (1.2)	3 (0.4)	0.06	−0.9 (−1.8 to 0.1)
Major thromboembolism or major bleeding	16 (2.5)	12 (1.5)	0.16	−1.0 (−2.5 to 0.5)
Major thromboembolism or major bleeding, or death	16 (2.5)	13 (1.6)	0.23	−0.9 (−2.3 to 0.6)